Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Teva Pharmaceutical Is in Recovery - WSJ
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva shares surge after announcing global opioid settlement
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
These Drug Companies Are Too Frail to Cure - WSJ
